Pfizer and GSK "best overall" viewed by managed care medics
Pfizer and GlaxoSmithKline tied for number one as the best overall pharmaceutical company among managed care medical directors in Verispan's fall 2006 Managed Care Medical Director Promotional Audit. The overall ranking is calculated based on five assessment areas: clinical objectivity, value-added services, disease management, account personnel and corporate approach.
Pfizer was ranked first for value-added services in the fall by medical directors. One panelist said, "superior commitment to physician education and managed care support," while another commented, "works with all divisions of the company; provides education, quality initiatives, nurse and physician education." The company was also appreciated for its Medicare Part D support, receiving the highest score among drugmakers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze